Prof. Paul Zimmet attended the recent Sunway Biomedical Symposium. |
The major cost of diabetes is its complications. Professor Cooper’s presentation highlighted new approaches to these complications such as SGLT2 Inhibitors and GLP-1 analysis, which appear to offer end-organ protection independent of their glucose lowering effects.